Online ECHO Clinic | May 21, 2020

Presentation Title: “Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine)

Dr. Ximena Levander, an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen and determine next steps for further confirmatory testing and to recognize the emergence of novel psychoactive substances and the challenges of monitoring and reporting in a rapidly changing drug-use landscape.


Video

Presenter Bios

Ximena A. Levander, MD, is an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University.

Presentation Slides

“Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine)

Resources Shared

Novel Psychoactive Substances

Confidently Identify Controlled Substances/Seized Drugs Whether In or Out of Your Laboratory